KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dynavax Technologies (DVAX) EBITDA Margin: 2009-2025

Historic EBITDA Margin for Dynavax Technologies (DVAX) over the last 17 years, with Sep 2025 value amounting to 22.42%.

  • Dynavax Technologies' EBITDA Margin rose 992.00% to 22.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.16%, marking a year-over-year increase of 737.00%. This contributed to the annual value of -1.49% for FY2024, which is 1445.00% up from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' EBITDA Margin is 22.42%, which was up 48.30% from 15.12% recorded in Q2 2025.
  • Over the past 5 years, Dynavax Technologies' EBITDA Margin peaked at 50.00% during Q2 2022, and registered a low of -64.46% during Q1 2023.
  • Over the past 3 years, Dynavax Technologies' median EBITDA Margin value was -2.27% (recorded in 2024), while the average stood at -8.44%.
  • Per our database at Business Quant, Dynavax Technologies' EBITDA Margin skyrocketed by 89,216bps in 2021 and then tumbled by 9,145bps in 2023.
  • Dynavax Technologies' EBITDA Margin (Quarterly) stood at 41.38% in 2021, then crashed by 716bps to 34.22% in 2022, then crashed by 4,949bps to -15.27% in 2023, then surged by 1,301bps to -2.27% in 2024, then skyrocketed by 992bps to 22.42% in 2025.
  • Its EBITDA Margin was 22.42% in Q3 2025, compared to 15.12% in Q2 2025 and -34.67% in Q1 2025.